References for Natural Progesterone

1. "What Your Doctor May Not Tell You About Menopause"
   John R. Lee, MD. Warner Books, May, 1996.

2. Chakmakjian, Z. Bioavailabliity of progesterone with different modes of adminsitration.
   J Reproductive Med 32, 443, 1987.

3. Chang, K.J. et. al. Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo.
   Fertility and Sterility 63: 785-91, 1995

4. Johnson, Blankenschtein and Langer, 1995, "Permeation of Steroids Through Human Skin."
   Journal of Pharmaceutical Sciences, Vol. 84, No. 9, Sept. 1995. Pages 1144-1146.

5. Albright, F. 1936. Studies in ovarian function III: the menopause.
   Endocrinology 20:24

6. Reyes, F.L., J.S. Winter, and C. Paiman. 1977. Pituitary ovarian relationships preceding the menopause: a cross-sectional study of serum follicle-stimulating hormone, luteinizing hormone, prolactin, estradiol and progesterone levels.
   American Journal of Obstetrics and Gynecology 129:557-64

7. Prior, J.C. 1990. Progesterone as a bone-trophic hormone.
   Endocr Rev 11:386-98

8. Coronary Drug Project Research Group. 1973. Coronary drug project: findings leading to the discontinuation of the 2.5 mg/day estrogen group.
   Journal of the American Medical Association 226:652-57

9. Lipsett, M.P. Steroid hormones, in Reproductive Endocrinology, Physiology, and Clinical Management. Yen, S.S.C., and R.B. Jaffe, eds. Philadelphia
   W.B. Saunders Co., 1978:80

10. Hileman, Beth. 1994. Reproductive estrogens linked to reproductive abnormalities, cancer.
    Chemical and Engineering News, January 31: 19-23.

11. Weiss, Rick. 1994. Estrogen in the environment.
    The Washington Post, January 25: 10-13.

12. Raloff, J. 1994. The gender benders.
    Science News 145, January 8: 24-27.

13. History of progesterone as described by Goodman & Gilman.
    The Pharmacological Basis of Therapeutics. 6th edition, 1980: chapter 61 (Estrogens and Progestins: 1420), 1085-1171

14. Campbell, B.C., and P.T. Ellison. 1992. Menstrual variation in salivary testosterone among regularly cycling women.
    Horm Res 37:132-36.

15. Hargrove, J.T., W.S. Maxson, A.C. Wentz, and L.S. Burnett. 1989. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Obstetrics & Gynecology 71:606-12

16. Stevenson, J.C., K.F. Ganger, et al. 1990. Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women.
    Lancet 336:265-26.

17. Ottoson, U.B., B.G. Johansson, and B. von Schoultz. 1985. Subtractions of high-density lipoprotein cholesterol during estrogen replacement therapy: a comparison between progestogens and natural progesterone.
    American Journal of Obstetrics and Gynecology 151:746-50.

18. Gambrell, R.D. 1982. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Fertil Steril 37: 457-74.

19. Scientific American Medicine, updated 1992.
    New York: Scientific American, chapter 15 (X):9.

20. Bergkvist, L., H.O. Adami, I. Persson, R. Hoover, and C. Schairer. 1989. The risk of breast cancer after estrogen and estrogen-progestin replacement.
    New England Journal of Medicine 321:293-97.

21. Leary, Warren E. 1995. Progesterone may play major role in the prevention of nerve disease.
    New York Times, June 27, C3.

22. Braverman, Eric. 1991. Natural estrogen and progesterone research indicates health benefits of natural vs. Synthetic hormones.
    Total Health 13, no. 5 (October): 55.

23. Prior, J.C., Y. M. Vigna, and N. Alojado. 1991. Progesterone and the prevention of osteoporosis.
    Canadian Journal of Obstetrics/Gynecology & Women’s Health Care 3:178-84.

24. Hammond, C.B., F.R. Jelvsek, K.L. Lee, W.T. Creasman, and R.T. Parker. 1979. Effects of long-term estrogen replacement therapy. I. Metabolic effects.
    American Journal of Obstetrics and Gynecology 133:525-36.

25. Lee, J.R. M.D., 1990. Osteoporosis reversal: the role of progesterone.
    Intern Clin Nutr Rev 10:384-91.

26. Lee, J.R. M.D., 1990. Osteoporosis reversal with transdermal progesterone (letter).
    Lancet 336:1327.

27. Lee, J.R. M.D., 1991. Is natural progesterone the missing link in osteoporosis prevention and treatment?
    Medical Hypotheses 35:316-18.

28. Lee, John R., M.D., 1994, Slowing the Aging Process with Natural Progesterone
    BLL Publishing, California, USA, p. 12.

29. Nolan, Charles R., M.D. et al. 1994. Aluminum and lead absorption from dietary sources in women ingesting calcium citrate.
    Southern Medical Journal. September, 87(9):894-98.

30. Lees, B., T. Molleson, T.R. Arnett, and J.C. Stevenson. 1993. Differences in proximal femur density over two centuries.
    Lancet 341:673-75.

31. Wilson, P.W.F., R. J. Garrison, and W.P. Castelli. 1985. Post-menopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50.
    New England Journal of Medicine 313:1038-43.

32. Tribble, D.L., and E. Frank. 1994. Dietary antioxidants, cancer, and atherosclerotic heart disease.
    W J Med 161:605-12.

33. Henderson, B.E., R.K. Ross, M.C. Pike, and J.T. Casagrande. 1982. Endogenous hormones as a major factor in human cancer.
    Cancer Research 42:3232-39.